UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000006868
Receipt number R000008016
Scientific Title Phase II study of efficacy of Bevacizumab plus chemotherapy for malignant pleural effusion (MPE) management of treated or untreated non-squamous non-small lung cancer(NSCLC) patients with uncontrollable MPEs by pleurodesis (NEJ-013B-2)
Date of disclosure of the study information 2011/12/10
Last modified on 2016/12/17 21:08:34

No. Disposal Last modified on Item of update
1 Insert 2011/12/10 14:12:22
2 Update 2012/01/23 16:48:39 Recruitment status
Date of protocol fixation
3 Update 2012/01/23 16:49:12 Research ethics review
4 Update 2013/06/18 22:17:52 Public title
Public title
Acronym
Acronym
5 Update 2013/06/18 22:36:11 Narrative objectives1
Narrative objectives1
Primary outcomes
Key secondary outcomes
Key secondary outcomes
6 Update 2013/06/18 22:37:47 Key secondary outcomes
7 Update 2013/06/18 22:44:35 Interventions/Control_1
Interventions/Control_1
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
8 Update 2013/06/18 22:48:33 Last name of contact person
Last name of contact person
Email
Name of person sending information
Name of person sending information
9 Update 2013/10/04 11:01:44 UMIN ID1
10 Update 2014/06/11 00:34:05 Division name
Division name
TEL
Email
Division name
Division name
Address
Address
TEL
Division name
Division name
Email
11 Update 2015/06/13 00:06:07 Organization1
12 Update 2016/12/17 21:04:56 Recruitment status
13 Update 2016/12/17 21:08:34 Name of primary person or sponsor
Organization